Largest health care companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
UnitedHealth Group leads the 170 health care companies ranked by net assets, at CHF 84.4B, ahead of Pfizer (CHF 73B) and Johnson & Johnson (CHF 68.8B). Figures as of 19 Nov 2026, 05:12 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- UnitedHealth GroupCHF 84.4B
- Median
- CHF 2.2B
- Combined market value
- CHF 7.67T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Kymera TherapeuticsKYMR · Health Care | CHF 1.3B | CHF 8.7B | CHF 102.19 | 0.32% down | 87% up | ||
| 102 | LifeStance Health GroupLFST · Health Care | CHF 1.3B | CHF 4.4B | CHF 11.62 | 2.82% down | 129% up | ||
| 103 | InsuletPODD · Health Care | CHF 1.3B | CHF 8.2B | CHF 118.09 | 3.69% down | 58% down | ||
| 104 | CencoraCOR · Health Care | CHF 1.3B | CHF 56.1B | CHF 293.84 | 0.64% down | 3% down | ||
| 105 | PenumbraPEN · Health Care | CHF 1.2B | CHF 10.7B | CHF 270.46 | 0.47% up | 13% up | ||
| 106 | MSA SafetyMSA · Health Care | CHF 1.2B | CHF 5.8B | CHF 149.70 | 2.67% up | 11% up | ||
| 107 | Option Care HealthOPCH · Health Care | CHF 1.1B | CHF 4B | CHF 26.75 | 0.25% up | 14% up | ||
| 108 | Krystal BiotechKRYS · Health Care | CHF 1B | CHF 7.9B | CHF 266.03 | 5.62% up | 46% up | ||
| 109 | LivaNovaLIVN · Health Care | CHF 1B | CHF 4.4B | CHF 79.76 | 2.85% up | 71% up | ||
| 110 | RadNetRDNT · Health Care | CHF 919.5M | CHF 4.8B | CHF 60.59 | 4.14% down | 7% down | ||
| 111 | Lantheus HoldingsLNTH · Health Care | CHF 919.4M | CHF 5.6B | CHF 86.05 | 0.20% up | 93% up | ||
| 112 | Ligand PharmaceuticalsLGND · Health Care | CHF 858.1M | CHF 5B | CHF 252.00 | 1.67% up | 43% up | ||
| 113 | Legend BiotechLEGN · Health Care | CHF 845.4M | CHF 2.7B | CHF 13.71 | 0.87% up | 42% down | ||
| 114 | ChemedCHE · Health Care | CHF 826.2M | CHF 6B | CHF 461.22 | 0.01% down | 27% up | ||
| 115 | Oscar HealthOSCR · Health Care | CHF 824.8M | CHF 7.2B | CHF 23.26 | 7.61% down | 112% up | ||
| 116 | PACS GroupPACS · Health Care | CHF 798.7M | CHF 6.2B | CHF 39.06 | 4.63% down | 188% up | ||
| 117 | Praxis Precision MedicinesPRAX · Health Care | CHF 740.8M | CHF 7.2B | CHF 257.46 | 0.04% up | 61% up | ||
| 118 | ImmunovantIMVT · Health Care | CHF 719.3M | CHF 5.8B | CHF 27.98 | 0.12% down | 43% up | ||
| 119 | 10x GenomicsTXG · Health Care | CHF 671.8M | CHF 6.3B | CHF 48.15 | 1.37% up | 260% up | ||
| 120 | HaemoneticsHAE · Health Care | CHF 671.8M | CHF 4.7B | CHF 103.65 | 1.60% up | 61% up | ||
| 121 | Alnylam PharmaceuticalsALNY · Health Care | CHF 665.8M | CHF 16.9B | CHF 126.04 | 4.54% down | 66% down | ||
| 122 | Belite BioBLTE · Health Care | CHF 650M | CHF 5.4B | CHF 131.80 | 0.94% down | 31% up | ||
| 123 | CG OncologyCGON · Health Care | CHF 634.9M | CHF 6B | CHF 67.49 | 1.34% up | 85% up | ||
| 124 | InsmedINSM · Health Care | CHF 623.4M | CHF 22.2B | CHF 101.07 | 1.69% down | 40% down | ||
| 125 | Spyre TherapeuticsSYRE · Health Care | CHF 603.4M | CHF 8.1B | CHF 85.59 | 8.15% up | 286% up | ||
| 126 | Summit TherapeuticsSMMT · Health Care | CHF 555.8M | CHF 7.1B | CHF 8.86 | 1.59% down | 36% down | ||
| 127 | GlaukosGKOS · Health Care | CHF 553.5M | CHF 11.6B | CHF 196.63 | 4.18% down | 152% up | ||
| 128 | TG TherapeuticsTGTX · Health Care | CHF 546.7M | CHF 8.4B | CHF 55.78 | 5.44% up | 107% up | ||
| 129 | Corcept TherapeuticsCORT · Health Care | CHF 546.5M | CHF 6.3B | CHF 57.19 | 3.25% down | 8% down | ||
| 130 | Cogent BiosciencesCOGT · Health Care | CHF 536.9M | CHF 4.1B | CHF 23.46 | 0.14% down | 20% down | ||
| 131 | Protagonist TherapeuticsPTGX · Health Care | CHF 518.6M | CHF 7B | CHF 107.27 | 2.00% up | 46% up | ||
| 132 | Madrigal PharmaceuticalsMDGL · Health Care | CHF 508.4M | CHF 7.8B | CHF 335.83 | 5.67% down | 24% down | ||
| 133 | Caris Life SciencesCAI · Health Care | CHF 487M | CHF 4.7B | CHF 16.45 | 2.21% down | 17% down | ||
| 134 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 478.8M | CHF 6.3B | CHF 80.19 | 0.06% down | 126% up | ||
| 135 | Hims & Hers HealthHIMS · Health Care | CHF 456.3M | CHF 3.4B | CHF 14.38 | 2.85% down | 51% down | ||
| 136 | Edgewise TherapeuticsEWTX · Health Care | CHF 440.6M | CHF 3.8B | CHF 34.90 | 1.59% down | 88% up | ||
| 137 | ABIVAXABVX · Health Care | CHF 426.1M | CHF 6.2B | CHF 70.72 | 2.11% up | 27% down | ||
| 138 | Dianthus TherapeuticsDNTH · Health Care | CHF 416.2M | CHF 4B | CHF 70.85 | 3.45% down | 113% up | ||
| 139 | Ionis PharmaceuticalsIONS · Health Care | CHF 412.6M | CHF 3.8B | CHF 23.11 | 1.59% up | 64% down | ||
| 140 | BillionToOneBLLN · Health Care | CHF 405M | CHF 3.7B | CHF 77.22 | 6.11% down | 0% up | ||
| 141 | Twist BioscienceTWST · Health Care | CHF 399M | CHF 6.7B | CHF 98.16 | 3.88% up | 340% up | ||
| 142 | Oruka TherapeuticsORKA · Health Care | CHF 398.1M | CHF 5.5B | CHF 80.77 | 0.60% down | 241% up | ||
| 143 | Arrowhead PharmaceuticalsARWR · Health Care | CHF 393.2M | CHF 5.1B | CHF 36.37 | 0.28% up | 10% up | ||
| 144 | Medpace HoldingsMEDP · Health Care | CHF 387.3M | CHF 15.3B | CHF 545.71 | 0.95% down | 10% up | ||
| 145 | Concentra Group Holdings ParentCON · Health Care | CHF 331.8M | CHF 4.5B | CHF 35.42 | 0.94% down | 120% up | ||
| 146 | Definium TherapeuticsDFTX · Health Care | CHF 280.4M | CHF 3.4B | CHF 24.57 | 0.88% down | 169% up | ||
| 147 | ErascaERAS · Health Care | CHF 274.3M | CHF 4.1B | CHF 11.61 | 0.94% down | 403% up | ||
| 148 | Mirum PharmaceuticalsMIRM · Health Care | CHF 265.5M | CHF 5.1B | CHF 78.03 | 0.59% up | 31% up | ||
| 149 | HeartflowHTFL · Health Care | CHF 253.6M | CHF 3.4B | CHF 38.71 | 2.51% down | 73% up | ||
| 150 | Scholar Rock HoldingSRRK · Health Care | CHF 207.1M | CHF 4.9B | CHF 40.49 | 6.48% up | 14% up | ||
| 151 | Adaptive BiotechnologiesADPT · Health Care | CHF 184.6M | CHF 3.9B | CHF 24.01 | 0.11% down | 88% up | ||
| 152 | Kodiak SciencesKOD · Health Care | CHF 132.8M | CHF 5.4B | CHF 82.51 | 1.04% up | 396% up | ||
| 153 | Rhythm PharmaceuticalsRYTM · Health Care | CHF 117.3M | CHF 7B | CHF 100.42 | 2.08% up | 13% up | ||
| 154 | Travere TherapeuticsTVTX · Health Care | CHF 96.9M | CHF 4.1B | CHF 42.38 | 1.68% down | 44% up | ||
| 155 | Axsome TherapeuticsAXSM · Health Care | CHF 74.5M | CHF 5.9B | CHF 113.05 | 1.43% down | 7% down | ||
| 156 | Halozyme TherapeuticsHALO · Health Care | CHF 41.2M | CHF 9.2B | CHF 80.82 | 0.18% down | 37% up | ||
| 157 | Mettler-Toledo InternationalMTD · Health Care | -CHF 19.9M | CHF 29.2B | CHF 1,465.59 | 1.42% up | 22% up | ||
| 158 | Amneal PharmaceuticalsAMRX · Health Care | -CHF 59.7M | CHF 6.4B | CHF 18.46 | 3.60% up | 83% up | ||
| 159 | Guardant HealthGH · Health Care | -CHF 83.8M | CHF 16.6B | CHF 122.44 | 1.30% up | 44% up | ||
| 160 | VeradermicsMANE · Health Care | -CHF 102.1M | CHF 4.4B | CHF 105.33 | 0.62% down | 233% up | ||
| 161 | Ascendis PharmaASND · Health Care | -CHF 152.4M | CHF 15B | CHF 228.06 | 0.32% down | 28% up | ||
| 162 | PTC TherapeuticsPTCT · Health Care | -CHF 173.2M | CHF 4.2B | CHF 50.81 | 0.22% down | 20% down | ||
| 163 | ImmunityBioIBRX · Health Care | -CHF 422.2M | CHF 6B | CHF 5.65 | 7.03% up | 193% up | ||
| 164 | DaVitaDVA · Health Care | -CHF 549.3M | CHF 8.6B | CHF 136.49 | 6.48% down | 50% up | ||
| 165 | CytokineticsCYTK · Health Care | -CHF 556.5M | CHF 6B | CHF 43.29 | 0.64% down | 20% down | ||
| 166 | BridgeBio PharmaBBIO · Health Care | -CHF 1.8B | CHF 12.8B | CHF 65.81 | 1.58% up | 17% up | ||
| 167 | McKessonMCK · Health Care | -CHF 1.8B | CHF 105.6B | CHF 914.85 | 0.66% down | 28% up | ||
| 168 | Cardinal HealthCAH · Health Care | -CHF 2.4B | CHF 54.3B | CHF 234.80 | 0.33% down | 35% up | ||
| 169 | AbbVieABBV · Health Care | -CHF 2.8B | CHF 426.5B | CHF 241.28 | 2.33% down | 26% up | ||
| 170 | HCA HealthcareHCA · Health Care | -CHF 5.1B | CHF 83.9B | CHF 401.86 | 4.96% down | 4% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8436 CHF).
Questions and answers
Which health care companies rank first by net assets?
UnitedHealth Group (CHF 84.4B), Pfizer (CHF 73B) and Johnson & Johnson (CHF 68.8B) are the top three of the 170 health care companies ranked by net assets as of 19 Nov 2026, 05:12 UTC.
How many health care companies are in this ranking?
170 are ranked by net assets.
What are these health care companies worth together?
The 170 health care companies ranked by net assets have a combined market value of CHF 7.67T as of 19 Nov 2026, 05:12 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by net assets”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.